Affinity Asset Advisors, LLC Q2 2022 Filing
Filed August 12, 2022
Portfolio Value
$237.2B
Holdings
49
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (49 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ESTAESTABLISHMENT LABS HLDGS INC | 509,956 | $27.7B | 11.69% | Put |
| 2 | KURAKURA ONCOLOGY INC | 928,256 | $17.0B | 7.17% | |
| 3 | 290ACHINOOK THERAPEUTICS INC | 937,568 | $16.4B | 6.91% | |
| 4 | NARIUSDINARI MED INC | 222,173 | $15.1B | 6.37% | |
| 5 | LNTHLANTHEUS HLDGS INC | 210,000 | $13.9B | 5.85% | Put |
| 6 | ASNDASCENDIS PHARMA A/S | 125,087 | $11.6B | 4.90% | |
| 7 | KRTXKARUNA THERAPEUTICS INC | 90,000 | $11.4B | 4.80% | Put |
| 8 | TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | 11,000,000 | $10.9B | 4.60% | |
| 9 | LLYLILLY ELI & CO | 30,000 | $9.7B | 4.10% | Call |
| 10 | NVV1NOVAVAX INC | 175,000 | $9.0B | 3.79% | Put |
| 11 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 10,000,000 | $8.0B | 3.38% | |
| 12 | MDGLMADRIGAL PHARMACEUTICALS INC | 100,000 | $7.2B | 3.02% | |
| 13 | HZNPHORIZON THERAPEUTICS PUB L | 75,000 | $6.0B | 2.52% | |
| 14 | AZNASTRAZENECA PLC | 85,000 | $5.6B | 2.37% | |
| 15 | TCE2CELLDEX THERAPEUTICS INC NEW | 185,000 | $5.0B | 2.10% | Call |
| 16 | MORFMORPHIC HLDG INC | 215,723 | $4.7B | 1.97% | |
| 17 | BLUBELLUS HEALTH INC NEW | 493,278 | $4.6B | 1.92% | |
| 18 | RPTXREPARE THERAPEUTICS INC | 321,200 | $4.5B | 1.89% | |
| 19 | CRSPCRISPR THERAPEUTICS AG | 70,000 | $4.3B | 1.79% | Call |
| 20 | BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | 10,000,000 | $4.2B | 1.79% | |
| 21 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 7,500,000 | $4.2B | 1.75% | |
| 22 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,372,244 | $4.0B | 1.71% | |
| 23 | RCKTROCKET PHARMACEUTICALS INC | 250,466 | $3.4B | 1.45% | |
| 24 | —ARYA SCIENCES ACQUISITN CORP | 352,500 | $3.4B | 1.44% | |
| 25 | LEGNLEGEND BIOTECH CORP | 50,000 | $2.8B | 1.16% | Call |
| 26 | MRNAMODERNA INC | 15,000 | $2.1B | 0.90% | Call |
| 27 | ZNTLZENTALIS PHARMACEUTICALS INC | 70,000 | $2.0B | 0.83% | |
| 28 | CNTXCONTEXT THERAPEUTICS INC | 883,654 | $1.9B | 0.79% | |
| 29 | —VINCERX PHARMA INC | 1,374,098 | $1.8B | 0.76% | |
| 30 | FATEFATE THERAPEUTICS INC | 67,500 | $1.7B | 0.71% | Call |
| 31 | IOVAIOVANCE BIOTHERAPEUTICS INC | 150,000 | $1.7B | 0.70% | Call |
| 32 | ACRSACLARIS THERAPEUTICS INC | 100,000 | $1.4B | 0.59% | |
| 33 | ACLXARCELLX INC | 75,000 | $1.4B | 0.57% | |
| 34 | NAUTNAUTILUS BIOTECHNOLOGY INC | 466,607 | $1.3B | 0.53% | |
| 35 | COGTCOGENT BIOSCIENCES INC | 125,000 | $1.1B | 0.48% | |
| 36 | TERNTERNS PHARMACEUTICALS INC | 401,268 | $995.0M | 0.42% | |
| 37 | LIANYLIANBIO | 450,000 | $972.0M | 0.41% | |
| 38 | SPRYSILVERBACK THERAPEUTICS INC | 170,000 | $721.0M | 0.30% | |
| 39 | CELUCELULARITY INC | 183,600 | $624.0M | 0.26% | Put |
| 40 | CYTKCYTOKINETICS INC | 15,000 | $589.0M | 0.25% | |
| 41 | —SCIENCE 37 HOLDINGS INC | 279,775 | $562.0M | 0.24% | |
| 42 | —RENOVACOR INC | 199,490 | $405.0M | 0.17% | |
| 43 | ENOBGBPENOCHIAN BIOSCIENCES INC | 200,000 | $386.0M | 0.16% | Put |
| 44 | IMTXIMMATICS N.V | 187,204 | $382.0M | 0.16% | |
| 45 | —CURIS INC | 340,349 | $335.0M | 0.14% | |
| 46 | VRDNVIRIDIAN THERAPEUTICS INC | 20,660 | $239.0M | 0.10% | |
| 47 | —POINT BIOPHARMA GLOBAL INC | 25,578 | $174.0M | 0.07% | |
| 48 | —MEDICUS SCIENCES ACQUISITION | 33,333 | $8.0M | 0.00% | |
| 49 | —RENOVACOR INC | 75,000 | $5.0M | 0.00% |